|

QL2107 Clinical Trials

3 actively recruiting trials

Pipeline

Phase 3: 1Phase 1/2: 2

Top Sponsors

  • Qilu Pharmaceutical Co., Ltd.3

Indications

  • Cancer3
  • Advanced Solid Tumor2
  • NSCLC1
  • Lung Cancer1

Other3 trials

A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
Phase 1/2
A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
Phase 1/2
A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.